65 related articles for article (PubMed ID: 23171856)
21. Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients.
Ali-Erdem M; Burak-Cankaya A; Cemil-Isler S; Demircan S; Soluk M; Kasapoglu C; Korhan-Oral C
Med Oral Patol Oral Cir Bucal; 2011 Nov; 16(7):e879-83. PubMed ID: 21743422
[TBL] [Abstract][Full Text] [Related]
22. Association between IL13 gene polymorphisms and susceptibility to cancer: a meta-analysis.
Su T; Mi Y; Zhang L; Wang S; Lu H; Shi L; Sun H; Wu X; Zhang W; Zuo L; Zou J
Gene; 2013 Feb; 515(1):56-61. PubMed ID: 23246181
[TBL] [Abstract][Full Text] [Related]
23. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
[TBL] [Abstract][Full Text] [Related]
24. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
25. [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration].
Adam Z; Kozumpliková M; Pour L; Machálka M
Vnitr Lek; 2006 Feb; 52(2):176-80. PubMed ID: 16623282
[TBL] [Abstract][Full Text] [Related]
26. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
Wang EP; Kaban LB; Strewler GJ; Raje N; Troulis MJ
J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate osteo-necrosis of the jaws [BONJ], from defective function of oral epithelial intercellular junctions?
Touyz LZ
Med Hypotheses; 2015 May; 84(5):474-6. PubMed ID: 25697117
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
Hewson ID
N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837
[TBL] [Abstract][Full Text] [Related]
29. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws.
Treister NS; Richardson P; Schlossman R; Miller K; Woo SB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):e1-4. PubMed ID: 18417376
[TBL] [Abstract][Full Text] [Related]
30. A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.
English BC; Baum CE; Adelberg DE; Sissung TM; Kluetz PG; Dahut WL; Price DK; Figg WD
Ther Clin Risk Manag; 2010 Nov; 6():579-83. PubMed ID: 21151627
[TBL] [Abstract][Full Text] [Related]
31. Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw.
Allegra A; Mania M; D'Ascola A; Oteri G; Siniscalchi EN; Avenoso A; Innao V; Scuruchi M; Allegra AG; Musolino C; Campo S
Biomed Res Int; 2020; 2020():9879876. PubMed ID: 32714991
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting.
Krüger TB; Sharikabad MN; Herlofson BB
Acta Odontol Scand; 2013 Nov; 71(6):1386-90. PubMed ID: 23351164
[TBL] [Abstract][Full Text] [Related]
33. Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw.
Najm MS; Solomon DH; Woo SB; Treister NS
Oral Dis; 2014 Jan; 20(1):94-9. PubMed ID: 23419136
[TBL] [Abstract][Full Text] [Related]
34. The impact of genetic variants in the
Qu W; Zhang F; Cheng Y; Li J; Zhou J
Front Endocrinol (Lausanne); 2022; 13():989030. PubMed ID: 36246885
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review.
Varun B; Sivakumar T; Nair BJ; Joseph AP
J Oral Maxillofac Pathol; 2012 May; 16(2):210-4. PubMed ID: 22923892
[TBL] [Abstract][Full Text] [Related]
36. [Bisphosphonate-associated osteonecrosis of the jaws].
Wang S; Zheng W
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Nov; 48(11):699-700. PubMed ID: 24513078
[No Abstract] [Full Text] [Related]
37. Bisphosphonate-Related Osteonecrosis and Metastasis Within the Same Site of the Jaw: Expected for Multiple Myeloma, But Unusual for Breast Cancer.
Altundag K
J Oral Maxillofac Surg; 2017 Jul; 75(7):1309-1310. PubMed ID: 28384466
[No Abstract] [Full Text] [Related]
38. In Reply.
Corsi A; Ungari C; Riminucci M; Agrillo A
J Oral Maxillofac Surg; 2017 Jul; 75(7):1310. PubMed ID: 28384460
[No Abstract] [Full Text] [Related]
39. Skeletal-Related Events in Patients With Multiple Myeloma and Prostate Cancer Who Receive Standard vs Extended-Interval Bisphosphonate Dosing.
Shell A; Keough LA; Rajanna K
Fed Pract; 2019 Feb; 36(Suppl 1):S22-S26. PubMed ID: 30867632
[TBL] [Abstract][Full Text] [Related]
40. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
